Site Planning Begins for Cancer Institute Expansion Phases 3 & 4

Site Planning Begins for Cancer Institute Expansion Phases 3 & 4

The Sarasota County Public Hospital Board this week authorized Sarasota Memorial staff to move forward with preliminary site and design plans for 2 new outpatient oncology facilities: a new, 6-story cancer pavilion on the hospital’s Sarasota campus and a 2-story cancer center on its developing Venice hospital campus.

Wednesday, April 21, 2021
Quinoa Stir Fry | Healthy Cooking with Thrive

Quinoa Stir Fry | Healthy Cooking with Thrive

In this month's Thrive in the Kitchen healthy-cooking demo video, our team shows you how to make Quinoa Stir Fry with Bok Choy. A great vegetarian source of protein and fiber, quinoa is partnered with delicious veggies to boost the immune system, lower blood pressure and help the body break down potential carcinogens.

Monday, April 19, 2021
SMH Joins Drug Study to Reduce Dangerous Inflammation in COVID-19 Patients

SMH Joins Drug Study to Reduce Dangerous Inflammation in COVID-19 Patients

Sarasota Memorial Hospital is one of more than a dozen research sites across the nation participating in the multi-center trial of IC14, an anti-CD14 monoclonal antibody drug that researchers hope will reduce dangerous levels of inflammation in COVID-19 patients. This week, SMH became the first U.S. site to enroll a patient in the phase 2 trial, called the COVID-19 anti-CD14 Treatment Trial (CaTT). 

Thursday, April 15, 2021
Coping with Cancer

Coping with Cancer

Every cancer journey is a rollercoaster, physically and emotionally. But patients can learn to cope with cancer. If you’re navigating your own cancer journey, learn to live well with the disease with these steps from SMH Oncology Clinical Counselor Elizabeth Bornstein.

Tuesday, April 13, 2021
COVID-19 Treatment Offered at SMH Shows Promising Results

COVID-19 Treatment Offered at SMH Shows Promising Results

A monoclonal antibody cocktail developed by Regeneron cut the risk of hospitalization and death by 70% when given to high-risk COVID-19 patients in a large clinical trial, the drug maker announced last week. SMH was among 27 sites participating in the trial.

Wednesday, March 31, 2021
RSS
First171172173174176178179180Last